Action Observation Treatment in Parkinson's Patients
AOT-PA
Action Observation Treatment and Motor Imagery as Rehabilitation Tools in Parkinson's Disease Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of the study is to assess the role of Action Observation Treatment (AOT) and Motor Imagery (MI) in the rehabilitation of Parkinson's disease patients, as compared to a control condition. Main outcome measures will be the results in two functional scales (FIM, UPDRS) and kinematics parameters obtained from gait analysis. Data at two months and six months follow up, respectively, will be also collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 26, 2018
CompletedFirst Submitted
Initial submission to the registry
November 18, 2019
CompletedFirst Posted
Study publicly available on registry
December 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2020
CompletedDecember 2, 2019
May 1, 2019
2 years
November 18, 2019
November 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
change in the functional status of the patient
to assess the change in the functional status of the patient, the Functional Independence Measure (FIM) will be used. FIM consists in a 7-point scale (1 = \<25% independence; total assistance required, 7 = 100% independence), and it can detect changes in the patient's status in 18 categories, focusing on motor and cognitive function. Functional patients' status will assess before treatment, within one week after the end of the treatment (after treatment) and two months' follow up.
Before treatment, within one week after treatment, two months' follow up
change in Parkinson disease motor symptoms
to assess the change in motor status of the patient, the Unified Parkinson's Disease Rating Scale (UPDRS) will be used, and it consists in a 5-point scale (0 = no signs; 4 = severe). UPDRS will be administered before treatment, within one week after the end of the treatment (after treatment) and two months' follow up.
Before treatment, within one week after treatment, two months' follow up
change in kinematic parameters of the gait (velocity, footing, pace, step length)
to assess the change of patient's gait parameters, the kinematic analysis will be used (i.e. gait analysis). The gait analysis allows to detect fine-grain changes in kinematic parameters of the movement, through a non-invasive methodology. Gait analysis will be performed before treatment, within one week after the end of the treatment (after treatment) and two months' follow up.
Before treatment, within one week after treatment, two months' follow up
Study Arms (3)
AOT
EXPERIMENTALThis group will observe videos depicting daily actions and afterwards they will execute the seen actions
MI
EXPERIMENTALThis group will imagine motorically the same action as the first group and afterwards they will execute the imagined actions
Control
NO INTERVENTIONThis group will neither observe nor imagine actions, but simply observe videos with no motor content. Afterwards they will execute the same actions as in AOT and MI.
Interventions
During action observation, participants observe different daily actions (e.g. reading a newspaper; drinking an espresso) divided into up to four motor segments.
During motor imagery, participants imagine themselves performing the same daily actions as in AOT in the absence of motor output
Eligibility Criteria
You may qualify if:
- Parkinson disease patients on Hoehn and Yahr 3-4
You may not qualify if:
- Mini-Mental State Examination \< 24
- Fluent aphasic patients
- Apraxia
- Neglect
- major neuropsychiatric disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Don Carlo Gnocchi
Parma, 43123, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Giovanni Buccino
Istituto Don Gnocchi
- STUDY CHAIR
Claudio Rovacchi
Istituto Don Gnocchi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2019
First Posted
December 2, 2019
Study Start
March 26, 2018
Primary Completion
March 26, 2020
Study Completion
June 26, 2020
Last Updated
December 2, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share